PATH
Seattle, Washington, United States
Purpose
to evaluate the relative efficacy of a trivalent P2-VP8 parenteral rotavirus vaccine compared to a licensed live oral rotavirus vaccine to prevent severe rotavirus gastroenteritis in infants residing in lower-income settings.
Division
Global Health
Date
January 2019
Region Served
GLOBAL
Committed amount
$24,473,458
Grant topic
Enterics, Diagnostics, Genomics & Epidemiology
Duration (months)
81
Grantee location
Seattle, Washington, United States
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.